MARKET

ATRC

ATRC

AtriCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

28.03
+0.14
+0.50%
Opening 12:48 11/12 EST
OPEN
27.93
PREV CLOSE
27.89
HIGH
28.38
LOW
27.91
VOLUME
36.36K
TURNOVER
--
52 WEEK HIGH
34.39
52 WEEK LOW
22.57
MARKET CAP
1.11B
P/E (TTM)
-44.1209
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATRC News

  • AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference
  • Business Wire.4h ago
  • Edited Transcript of ATRC earnings conference call or presentation 30-Oct-19 8:30pm GMT
  • Thomson Reuters StreetEvents.5d ago
  • AtriCure, Inc. (ATRC) CEO Mike Carrel on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/03 12:48
  • AtriCure EPS beats by $0.06, beats on revenue
  • seekingalpha.10/31 01:15

More

Industry

Medical Equipment, Supplies & Distribution
+0.66%
Healthcare Equipment & Supplies
+0.69%

Hot Stocks

Name
Price
%Change

About ATRC

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
More

Webull offers AtriCure Inc. (ATRC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.